- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Sichuan PriMed Shines BioTech Co., Ltd.
Sichuan PriMed Shines BioTech Co., Ltd. is listed as a mid sized business research supplier in the Scientist.com network, with 2 sites in 1 country.
View Sichuan PriMed Shines BioTech Co., Ltd. on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
2
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Mid sized business
Disease Models
- Arthritis Models Measure therapeutic endpoints in animal models of arthritis.
- Bacterial Infection Models Measure therapeutic endpoints in animal models of bacterial infection.
- Behavioral Testing Models Investigate sensory-motor and emotional functions, social behavior and day-night activity.
- Bone Models Measure therapeutic endpoints in animal models of bone disorders.
- Cardiovascular Metabolics Models Measure therapeutic endpoints in animal models of cardiovascular disorders.
- Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
Show all 27 in Disease Models
- Cataract Models Measure therapeutic endpoints in animal models of cataracts.
- Chronic Kidney Disease Models Measure therapeutic endpoints in animal models of chronic kidney disease.
- Diabetic Retinopathy Models Assess therapeutic efficacy of drug candidates in diabetic retinopathy models of disease.
- Dry Eye Models Measure therapeutic endpoints such as tear induction, TBUT, Schirmer strips (tear volume) and cornea staining.
- Infectious Disease Models Test therapeutic efficacy of drug candidate in infectious disease model.
- Inflammation Models Measure therapeutic endpoints in animal models for inflammation.
- Ischemia Models Measure therapeutic endpoints in animal models of ischemia.
- Liver Disease Animal Models Measure therapeutic endpoints in animal models with liver disease.
- Liver Fibrosis Models Measure liver fibrosis using therapeutic endpoints such as collagen assessment, TUNEL staining and inflammatory markers.
- Macular Degeneration Models Use a single animal species to create one or more models for eye disease.
- Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
- Obese Primates Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
- Ocular Inflammation Models Measure ocular inflammation in models of eye disorders such as uveitis and keratitis.
- Ophthalmic Models Test drug candidates in glaucoma, macular degeneration, keratitis, uveitis and CMV retinitis models.
- Osteoarthritis Models Measure therapeutic endpoints in animal models of osteoarthritis.
- Otology Models Measure vertigo, tinnitus, otitis media and hearing loss in animal models.
- Pain Models Test therapeutic efficacy of drug candidate in pain model.
- Parkinson's Disease Models Measure therapeutic endpoints in animal models of Parkinson's disease.
- Sclerosis ALS Models Measure therapeutic endpoints in animal models of sclerosis.
- Thrombosis Models Measure therapeutic endpoints in animal models of thrombosis.
- Wound Healing Models Measure therapeutic endpoints in animal models of wound healing.
General in vivo Toxicology
- Oral Toxicology Use toxicity studies in animals to evaluate the oral toxicity of a drug candidate.
- Repeat Dose Toxicity Study - Monkey / Non-human Primate Conduct a repeat dose study in monkey/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Toxicity Study - Rat Conduct a repeat dose study in rats to determine the toxicity and toxicokinetic behavior of your compound.
- Single Dose Acute Toxicity Study - Monkey / Non-human Primate Conduct a single dose study in Monkeys and Non-human Primates to determine the toxicokinetic behavior of your compound.
In Vivo ADME
- Ocular Distribution Study - Monkey / Non-human Primate Conduct a study to determine the distribution of your compound in ocular tissues of the monkey/non-human primate.
In Vivo Pharmacokinetics
- In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
- Ocular Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
- Ocular Pharmacokinetic (PK) Screening - Rat Conduct a pharmacokinetic screening study in rats that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
- Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound.
Show all 47 services
Model Development
- Non-Human Primate Models Use a single animal species to create one or more disease models.
Non-Human Biospecimen
- Monkey / Non-Human Primate / NHP Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
- Monkey / Non-Human Primate / NHP Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
Specialty Dosing Routes
- Intracameral Implant Toxicity and/or Toxicokinetic Study - Monkey / Non-human Primate Conduct an intracameral implant toxicity study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Intravitreal Toxicity and/or Toxicokinetic Study - Monkey / Non-human Primate Conduct an intravitreal ocular toxicity study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Ophthalmologic Toxicology Measure toxicity by microscopy, vitrectomy, tonometry, electroretionography and corneal colorimetry.
- Repeat Dose Intranasal Study - Monkey / Non-human Primate Conduct a repeat dose intranasal study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intravenous Infusion Study - Monkey / Non-human Primate Conduct a repeat dose intravenous infusion study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Single Dose Acute Intravenous Infusion Study - Monkey / Non-human Primate Conduct a single dose intravenous infusion study in monkeys/non-human primates to determine the toxicokinetic behavior of your compound.
Show all 7 in Specialty Dosing Routes
- Topical Ocular Toxicity and/or Toxicokinetic Study - Monkey / Non-human Primate Conduct a topical ocular toxicity study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
Other services
- New Request
- Website
- www.primed.com.cn
Where it operates
Sites by country, with the cities in each.
-
China 2 sites
Work with Sichuan PriMed Shines BioTech Co., Ltd. on Scientist.com
For prices, more details, or to contact Sichuan PriMed Shines BioTech Co., Ltd., visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.